Global and Japan Hypertension Drug Market Insights, Forecast to 2026

1 Study Coverage

• 1.1 Hypertension Drug Product Introduction
• 1.2 Market Segments
• 1.3 Key Hypertension Drug Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Hypertension Drug Market Size Growth Rate by Type
  • 1.4.2 Calcium Channel Blockers
  • 1.4.3 Diuretics
  • 1.4.4 Beta Blockers Vasodilators
  • 1.4.5 Angiotensin Converting Enzyme Inhibitors
  • 1.4.6 Alpha Blockers
  • 1.4.7 Angiotensin Receptor Blockers
  • 1.4.8 Renin Inhibitors
• 1.5 Market by Application
  • 1.5.1 Global Hypertension Drug Market Size Growth Rate by Application
  • 1.5.2 Hospital
  • 1.5.3 Private clinic
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Hypertension Drug Market Size, Estimates and Forecasts
  • 2.1.1 Global Hypertension Drug Revenue 2015-2026
  • 2.1.2 Global Hypertension Drug Sales 2015-2026
• 2.2 Global Hypertension Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
• 2.3 Hypertension Drug Historical Market Size by Region (2015-2020)
  • 2.3.1 Global Hypertension Drug Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.3.2 Global Hypertension Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
• 2.4 Hypertension Drug Market Estimates and Projections by Region (2021-2026)
  • 2.4.1 Global Hypertension Drug Sales Forecast by Region (2021-2026)
  • 2.4.2 Global Hypertension Drug Revenue Forecast by Region (2021-2026)

3 Global Hypertension Drug Competitor Landscape by Players

• 3.1 Global Top Hypertension Drug Sales by Manufacturers
  • 3.1.1 Global Hypertension Drug Sales by Manufacturers (2015-2020)
  • 3.1.2 Global Hypertension Drug Sales Market Share by Manufacturers (2015-2020)
• 3.2 Global Hypertension Drug Manufacturers by Revenue
  • 3.2.1 Global Hypertension Drug Revenue by Manufacturers (2015-2020)
  • 3.2.2 Global Hypertension Drug Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Hypertension Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Hypertension Drug Revenue in 2019
  • 3.2.5 Global Hypertension Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Global Hypertension Drug Price by Manufacturers
• 3.4 Global Hypertension Drug Manufacturing Base Distribution, Product Types
  • 3.4.1 Hypertension Drug Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Hypertension Drug Product Type
  • 3.4.3 Date of International Manufacturers Enter into Hypertension Drug Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Hypertension Drug Market Size by Type (2015-2020)
  • 4.1.1 Global Hypertension Drug Sales by Type (2015-2020)
  • 4.1.2 Global Hypertension Drug Revenue by Type (2015-2020)
  • 4.1.3 Hypertension Drug Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Hypertension Drug Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Hypertension Drug Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Hypertension Drug Revenue Forecast by Type (2021-2026)
  • 4.2.3 Hypertension Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Hypertension Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

• 5.1 Global Hypertension Drug Market Size by Application (2015-2020)
  • 5.1.1 Global Hypertension Drug Sales by Application (2015-2020)
  • 5.1.2 Global Hypertension Drug Revenue by Application (2015-2020)
  • 5.1.3 Hypertension Drug Price by Application (2015-2020)
• 5.2 Hypertension Drug Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Hypertension Drug Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Hypertension Drug Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Hypertension Drug Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

• 6.1 Japan Hypertension Drug Market Size YoY Growth 2015-2026
  • 6.1.1 Japan Hypertension Drug Sales YoY Growth 2015-2026
  • 6.1.2 Japan Hypertension Drug Revenue YoY Growth 2015-2026
  • 6.1.3 Japan Hypertension Drug Market Share in Global Market 2015-2026
• 6.2 Japan Hypertension Drug Market Size by Players (International and Local Players)
  • 6.2.1 Japan Top Hypertension Drug Players by Sales (2015-2020)
  • 6.2.2 Japan Top Hypertension Drug Players by Revenue (2015-2020)
• 6.3 Japan Hypertension Drug Historic Market Review by Type (2015-2020)
  • 6.3.1 Japan Hypertension Drug Sales Market Share by Type (2015-2020)
  • 6.3.2 Japan Hypertension Drug Revenue Market Share by Type (2015-2020)
  • 6.3.3 Japan Hypertension Drug Price by Type (2015-2020)
• 6.4 Japan Hypertension Drug Market Estimates and Forecasts by Type (2021-2026)
  • 6.4.1 Japan Hypertension Drug Sales Forecast by Type (2021-2026)
  • 6.4.2 Japan Hypertension Drug Revenue Forecast by Type (2021-2026)
  • 6.4.3 Japan Hypertension Drug Price Forecast by Type (2021-2026)
• 6.5 Japan Hypertension Drug Historic Market Review by Application (2015-2020)
  • 6.5.1 Japan Hypertension Drug Sales Market Share by Application (2015-2020)
  • 6.5.2 Japan Hypertension Drug Revenue Market Share by Application (2015-2020)
  • 6.5.3 Japan Hypertension Drug Price by Application (2015-2020)
• 6.6 Japan Hypertension Drug Market Estimates and Forecasts by Application (2021-2026)
  • 6.6.1 Japan Hypertension Drug Sales Forecast by Application (2021-2026)
  • 6.6.2 Japan Hypertension Drug Revenue Forecast by Application (2021-2026)
  • 6.6.3 Japan Hypertension Drug Price Forecast by Application (2021-2026)

7 North America

• 7.1 North America Hypertension Drug Market Size YoY Growth 2015-2026
• 7.2 North America Hypertension Drug Market Facts & Figures by Country
  • 7.2.1 North America Hypertension Drug Sales by Country (2015-2020)
  • 7.2.2 North America Hypertension Drug Revenue by Country (2015-2020)
  • 7.2.3 U.S.
  • 7.2.4 Canada

8 Europe

• 8.1 Europe Hypertension Drug Market Size YoY Growth 2015-2026
• 8.2 Europe Hypertension Drug Market Facts & Figures by Country
  • 8.2.1 Europe Hypertension Drug Sales by Country
  • 8.2.2 Europe Hypertension Drug Revenue by Country
  • 8.2.3 Germany
  • 8.2.4 France
  • 8.2.5 U.K.
  • 8.2.6 Italy
  • 8.2.7 Russia

9 Asia Pacific

• 9.1 Asia Pacific Hypertension Drug Market Size YoY Growth 2015-2026
• 9.2 Asia Pacific Hypertension Drug Market Facts & Figures by Country
  • 9.2.1 Asia Pacific Hypertension Drug Sales by Region (2015-2020)
  • 9.2.2 Asia Pacific Hypertension Drug Revenue by Region
  • 9.2.3 China
  • 9.2.4 Japan
  • 9.2.5 South Korea
  • 9.2.6 India
  • 9.2.7 Australia
  • 9.2.8 Taiwan
  • 9.2.9 Indonesia
  • 9.2.10 Thailand
  • 9.2.11 Malaysia
  • 9.2.12 Philippines
  • 9.2.13 Vietnam

10 Latin America

• 10.1 Latin America Hypertension Drug Market Size YoY Growth 2015-2026
• 10.2 Latin America Hypertension Drug Market Facts & Figures by Country
  • 10.2.1 Latin America Hypertension Drug Sales by Country
  • 10.2.2 Latin America Hypertension Drug Revenue by Country
  • 10.2.3 Mexico
  • 10.2.4 Brazil
  • 10.2.5 Argentina

11 Middle East and Africa

• 11.1 Middle East and Africa Hypertension Drug Market Size YoY Growth 2015-2026
• 11.2 Middle East and Africa Hypertension Drug Market Facts & Figures by Country
  • 11.2.1 Middle East and Africa Hypertension Drug Sales by Country
  • 11.2.2 Middle East and Africa Hypertension Drug Revenue by Country
  • 11.2.3 Turkey
  • 11.2.4 Saudi Arabia
  • 11.2.5 U.A.E

12 Company Profiles

• 12.1 Lupin Limited
  • 12.1.1 Lupin Limited Corporation Information
  • 12.1.2 Lupin Limited Description and Business Overview
  • 12.1.3 Lupin Limited Sales, Revenue and Gross Margin (2015-2020)
  • 12.1.4 Lupin Limited Hypertension Drug Products Offered
  • 12.1.5 Lupin Limited Recent Development
• 12.2 Novartis AG
  • 12.2.1 Novartis AG Corporation Information
  • 12.2.2 Novartis AG Description and Business Overview
  • 12.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
  • 12.2.4 Novartis AG Hypertension Drug Products Offered
  • 12.2.5 Novartis AG Recent Development
• 12.3 Daiichi - Sankyo
  • 12.3.1 Daiichi - Sankyo Corporation Information
  • 12.3.2 Daiichi - Sankyo Description and Business Overview
  • 12.3.3 Daiichi - Sankyo Sales, Revenue and Gross Margin (2015-2020)
  • 12.3.4 Daiichi - Sankyo Hypertension Drug Products Offered
  • 12.3.5 Daiichi - Sankyo Recent Development
• 12.4 Pfizer Inc
  • 12.4.1 Pfizer Inc Corporation Information
  • 12.4.2 Pfizer Inc Description and Business Overview
  • 12.4.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
  • 12.4.4 Pfizer Inc Hypertension Drug Products Offered
  • 12.4.5 Pfizer Inc Recent Development
• 12.5 Ranbaxy Laboratories Limited
  • 12.5.1 Ranbaxy Laboratories Limited Corporation Information
  • 12.5.2 Ranbaxy Laboratories Limited Description and Business Overview
  • 12.5.3 Ranbaxy Laboratories Limited Sales, Revenue and Gross Margin (2015-2020)
  • 12.5.4 Ranbaxy Laboratories Limited Hypertension Drug Products Offered
  • 12.5.5 Ranbaxy Laboratories Limited Recent Development
• 12.6 Sanofi S.A
  • 12.6.1 Sanofi S.A Corporation Information
  • 12.6.2 Sanofi S.A Description and Business Overview
  • 12.6.3 Sanofi S.A Sales, Revenue and Gross Margin (2015-2020)
  • 12.6.4 Sanofi S.A Hypertension Drug Products Offered
  • 12.6.5 Sanofi S.A Recent Development
• 12.7 AstraZeneca Plc
  • 12.7.1 AstraZeneca Plc Corporation Information
  • 12.7.2 AstraZeneca Plc Description and Business Overview
  • 12.7.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
  • 12.7.4 AstraZeneca Plc Hypertension Drug Products Offered
  • 12.7.5 AstraZeneca Plc Recent Development
• 12.8 Johnson & Johnson Ltd
  • 12.8.1 Johnson & Johnson Ltd Corporation Information
  • 12.8.2 Johnson & Johnson Ltd Description and Business Overview
  • 12.8.3 Johnson & Johnson Ltd Sales, Revenue and Gross Margin (2015-2020)
  • 12.8.4 Johnson & Johnson Ltd Hypertension Drug Products Offered
  • 12.8.5 Johnson & Johnson Ltd Recent Development
• 12.9 Boehringer Ingelheim
  • 12.9.1 Boehringer Ingelheim Corporation Information
  • 12.9.2 Boehringer Ingelheim Description and Business Overview
  • 12.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
  • 12.9.4 Boehringer Ingelheim Hypertension Drug Products Offered
  • 12.9.5 Boehringer Ingelheim Recent Development
• 12.10 Merck & Co.
  • 12.10.1 Merck & Co. Corporation Information
  • 12.10.2 Merck & Co. Description and Business Overview
  • 12.10.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
  • 12.10.4 Merck & Co. Hypertension Drug Products Offered
  • 12.10.5 Merck & Co. Recent Development
• 12.11 Lupin Limited
  • 12.11.1 Lupin Limited Corporation Information
  • 12.11.2 Lupin Limited Description and Business Overview
  • 12.11.3 Lupin Limited Sales, Revenue and Gross Margin (2015-2020)
  • 12.11.4 Lupin Limited Hypertension Drug Products Offered
  • 12.11.5 Lupin Limited Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter’s Five Forces Analysis
• 13.5 Primary Interviews with Key Hypertension Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Hypertension Drug Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details